"Drug Liberation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Release of drugs from DOSAGE FORMS into solution.
Descriptor ID |
D065546
|
MeSH Number(s) |
G02.211 G03.787.321 G07.690.725.321
|
Concept/Terms |
Drug Liberation- Drug Liberation
- Liberation, Drug
- Drug Release
- Release, Drug
- Drug Dissolution
- Dissolution, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Liberation".
Below are MeSH descriptors whose meaning is more specific than "Drug Liberation".
This graph shows the total number of publications written about "Drug Liberation" by people in this website by year, and whether "Drug Liberation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2014 | 1 | 0 | 1 |
2015 | 0 | 2 | 2 |
2017 | 0 | 1 | 1 |
2018 | 0 | 1 | 1 |
2019 | 0 | 1 | 1 |
2021 | 0 | 3 | 3 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Liberation" by people in Profiles.
-
Core-shell structured microneedles with programmed drug release functions for prolonged hyperuricemia management. J Mater Chem B. 2024 Jan 24; 12(4):1064-1076.
-
Formulation, Optimization, In Vitro and In Vivo Evaluation of Saxagliptin-Loaded Lipospheres for an Improved Pharmacokinetic Behavior. Biomed Res Int. 2021; 2021:3849093.
-
Ultra-long acting prodrug of dolutegravir and delivery system - Physicochemical, pharmacokinetic and formulation characterizations. Int J Pharm. 2021 Sep 25; 607:120889.
-
Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate? AAPS J. 2021 03 25; 23(3):48.
-
First-in-human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies. Invest New Drugs. 2021 08; 39(4):1047-1056.
-
Sustained delivery of a camptothecin prodrug - CZ48 by nanosuspensions with improved pharmacokinetics and enhanced anticancer activity. Int J Nanomedicine. 2019; 14:3799-3817.
-
A Poloxamer-407 modified liposome encapsulating epigallocatechin-3-gallate in the presence of magnesium: Characterization and protective effect against oxidative damage. Int J Pharm. 2018 Dec 01; 552(1-2):225-234.
-
Improvement of Anticancer Drug Release by Cobalt Ferrite Magnetic Nanoparticles through Combined pH and Temperature Responsive Technique. Chemphyschem. 2018 11 05; 19(21):2872-2878.
-
STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy. Biomaterials. 2018 05; 163:67-75.
-
Modified gold-based siRNA nanotherapeutics for targeted therapy of triple-negative breast cancer. Nanomedicine (Lond). 2017 Aug; 12(16):1961-1973.